{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:01:23Z","timestamp":1789203683296,"version":"build-2803163510"},"reference-count":24,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"DOI":"10.1210\/jc.2010-0086","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T20:46:26Z","timestamp":1273783586000},"page":"3763-3767","source":"Crossref","is-referenced-by-count":53,"title":["Plasma Adiponectin Levels Are Markedly Elevated in Imatinib-Treated Chronic Myeloid Leukemia (CML) Patients: A Mechanism for Improved Insulin Sensitivity in Type 2 Diabetic CML Patients?"],"prefix":"10.1210","volume":"95","author":[{"given":"Stephen","family":"Fitter","sequence":"first","affiliation":[{"name":"Department of Haematology (S.F., K.V., A.C.W.Z.), Myeloma Research Laboratory, Centre for Cancer Biology, Royal Adelaide Hospital, Adelaide 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Vandyke","sequence":"additional","affiliation":[{"name":"Department of Haematology (S.F., K.V., A.C.W.Z.), Myeloma Research Laboratory, Centre for Cancer Biology, Royal Adelaide Hospital, Adelaide 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Bone Densitometry (C.G.S.), Royal Adelaide Hospital, Adelaide 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"White","sequence":"additional","affiliation":[{"name":"Department of Haematology (D.W., T.P.H.), Institute of Medical and Veterinary Science, Royal Adelaide Hospital, Adelaide 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Haematology (D.W., T.P.H.), Institute of Medical and Veterinary Science, Royal Adelaide Hospital, Adelaide 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C. W.","family":"Zannettino","sequence":"additional","affiliation":[{"name":"Department of Haematology (S.F., K.V., A.C.W.Z.), Myeloma Research Laboratory, Centre for Cancer Biology, Royal Adelaide Hospital, Adelaide 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113533508000_R1","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1200\/JCO.2004.04.217","article-title":"Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment.","volume":"22","author":"Breccia","year":"2004","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113533508000_R2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.leukres.2009.02.024","article-title":"Hypolipemiant besides antileukemic effect of imatinib mesylate.","volume":"33","author":"Gologan","year":"2009","journal-title":"Leuk Res"},{"issue":"(Suppl)","key":"key\n\t\t\t\t2019041113533508000_R3","first-page":"ECR21","article-title":"Reduction of glycosylated hemoglobin with stable insulin levels in a diabetic patient with chronic myeloid leukemia responsive to imatinib.","volume":"90","author":"Breccia","year":"2005","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t2019041113533508000_R4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJM200503103521023","article-title":"Imatinib and regression of type 2 diabetes.","volume":"352","author":"Veneri","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113533508000_R5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.leukres.2007.08.014","article-title":"Restoration of insulin sensitivity following treatment with imatinib mesylate (Gleevec) in non-diabetic patients with chronic myelogenic leukemia (CML).","volume":"32","author":"Tsapas","year":"2008","journal-title":"Leuk Res"},{"key":"key\n\t\t\t\t2019041113533508000_R6","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1056\/NEJMc052500","article-title":"Imatinib and hyperlipidemia.","volume":"353","author":"Gottardi","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113533508000_R7","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/sj.onc.1208461","article-title":"Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation.","volume":"24","author":"Barnes","year":"2005","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019041113533508000_R8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1096\/fj.06-6910com","article-title":"Amelioration of diabetes by imatinib mesylate (Gleevec): role of \u03b2-cell NF-\u03baB activation and anti-apoptotic preconditioning.","volume":"21","author":"Ha\u0308gerkvist","year":"2007","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t2019041113533508000_R9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2337\/db08-0080","article-title":"Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db\/db mice.","volume":"58","author":"Han","year":"2009","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113533508000_R10","doi-asserted-by":"crossref","first-page":"18895","DOI":"10.1073\/pnas.0810246105","article-title":"Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice.","volume":"105","author":"Louvet","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113533508000_R11","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1182\/blood-2007-07-104281","article-title":"Long-term imatinib therapy promotes bone formation in CML patients.","volume":"111","author":"Fitter","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041113533508000_R12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2184.2007.00438.x","article-title":"Inhibition of platelet-derived growth factor receptor \u03b2 by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro.","volume":"40","author":"Fierro","year":"2007","journal-title":"Cell Prolif"},{"key":"key\n\t\t\t\t2019041113533508000_R13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","article-title":"Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis.","volume":"302","author":"Li","year":"2009","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113533508000_R14","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/diabetes.50.5.1126","article-title":"Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.","volume":"50","author":"Hotta","year":"2001","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113533508000_R15","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1210\/jcem.86.8.7741","article-title":"Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.","volume":"86","author":"Yang","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113533508000_R16","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","article-title":"Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.","volume":"98","author":"Fruebis","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113533508000_R17","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019041113533508000_R18","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1172\/JCI14120","article-title":"Endogenous glucose production is inhibited by the adipose-derived protein Acrp30.","volume":"108","author":"Combs","year":"2001","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113533508000_R19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/diabetes.55.01.06.db05-1105","article-title":"Adiponectin multimeric complexes and the metabolic syndrome trait cluster.","volume":"55","author":"Lara-Castro","year":"2006","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113533508000_R20","first-page":"614","article-title":"An Impact of the proton pump inhibitor on metabolic syndrome.","volume":"26","author":"Fumio","year":"2006","journal-title":"Prog Med"},{"key":"key\n\t\t\t\t2019041113533508000_R21","doi-asserted-by":"crossref","first-page":"39915","DOI":"10.1074\/jbc.M607215200","article-title":"SIRT1 regulates adiponectin gene expression through Foxo1-C\/enhancer-binding protein \u03b1 transcriptional complex.","volume":"281","author":"Qiao","year":"2006","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113533508000_R22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diabetes.52.3.667","article-title":"Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy.","volume":"52","author":"Phillips","year":"2003","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113533508000_R23","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1074\/jbc.M505311200","article-title":"Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor \u03b3 agonists.","volume":"281","author":"Nawrocki","year":"2006","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113533508000_R24","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1074\/jbc.M311113200","article-title":"Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.","volume":"279","author":"Pajvani","year":"2004","journal-title":"J Biol Chem"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/8\/3763\/9067715\/jcem3763.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:08:54Z","timestamp":1559092134000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/8\/3763\/2596800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,1]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2010-0086","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,1]]}}}